These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 8955597)

  • 1. External quality assurance as a revalidation method for pathologists in pediatric histopathology: Comparison of four international programs.
    Sergi C; Mikuz G
    BMC Clin Pathol; 2008 Nov; 8():11. PubMed ID: 19014480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smear tests: déjà vu.
    Nottingham J
    BMJ; 2001 Sep; 323(7311):517. PubMed ID: 11560149
    [No Abstract]   [Full Text] [Related]  

  • 3. Automated cytologic screening devices and malpractice liability.
    Skoumal SM; Cohen MB
    Diagn Cytopathol; 1997 Aug; 17(2):85-7. PubMed ID: 9258613
    [No Abstract]   [Full Text] [Related]  

  • 4. Criminalizing malpractice.
    DiMotto J
    Nurs Qual Connect; 1995; 5(1):1, 7. PubMed ID: 7663356
    [No Abstract]   [Full Text] [Related]  

  • 5. The cytology proficiency dilemma: the case for computer-based testing.
    Quarngesser SS
    Am Clin Lab; 1996; 15(10):18. PubMed ID: 10164049
    [No Abstract]   [Full Text] [Related]  

  • 6. Crisis in Newport.
    Chapman B
    CAP Today; 1994 Mar; 8(3):26-33. PubMed ID: 10150153
    [No Abstract]   [Full Text] [Related]  

  • 7. To err is human--to sue, American.
    DeMay RM
    Diagn Cytopathol; 1996 Sep; 15(3):iii-vi. PubMed ID: 8955597
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
    Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defending the pap smear: a proactive approach to the litigation threat in gynecologic cytology.
    McCoy DR
    Am J Clin Pathol; 2000 Nov; 114 Suppl():S52-8. PubMed ID: 11996170
    [No Abstract]   [Full Text] [Related]  

  • 10. Liability issues with the Papanicolaou smear: an insurance industry perspective.
    Scott MD
    Arch Pathol Lab Med; 1997 Mar; 121(3):239-40. PubMed ID: 9111107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liability issues with the Papanicolaou smear: the view of a hospital administrator at Newport Hospital, Newport, Rhode Island.
    Sampson AJ
    Arch Pathol Lab Med; 1997 Mar; 121(3):241-5. PubMed ID: 9111108
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.